Novavax, Inc. Dividend History (NVAX)
🤑 Novavax, Inc. has distributed a total of 6 dividends over the course of a year
About Novavax, Inc.
Novavax, Inc. is a biotechnology company founded in 1987, focusing on the development and commercialization of innovative vaccines to prevent serious infectious diseases. Headquartered in Gaithersburg, Maryland, Novavax gained significant attention for its work on a COVID-19 vaccine, among other viral threats. As of 2023, John C. Jacobs serves as the company's President and CEO, guiding its mission to improve global health through cutting-edge vaccine technology. Known for its recombinant nanoparticle technology, Novavax emphasizes rigorous research and development processes to create safe and effective vaccines. The company has made notable strides in public health, especially throughout the COVID-19 pandemic. Their emphasis on innovation continues to contribute substantially to their growth and presence in the biotech industry. Keep an eye on their financial reports to see how they continue to navigate and expand in a competitive market.
The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup. The appointment of RFK Jr. to lead the Department of Health and Human Services has spooked investors with his controversial policies and vaccine skepticism, leading to a decline in sector giants like Pfizer.
Investing.com · Published on Fri Nov 22 2024Previous Payouts (6)
The most recent dividend Novavax, Inc. paid out was on December 31, 2007 (6184 days ago) for $0.10625 per share
Pay Date | Amount |
---|---|
December 31, 2007 | $0.10625 |
November 30, 2007 | $0.10625 |
October 31, 2007 | $0.10625 |
September 28, 2007 | $0.10625 |
August 31, 2007 | $0.10625 |
July 31, 2007 | $0.10625 |
Dividend data last updated Thu, 05 Dec 2024 11:38:00 GMT UTC